Facebook Friday – Let’s talk about surgery with Prof Jas Samra

Overview

This week we had the pleasure of talking with Professor Jas Samra, from Royal North Shore Hospital in Sydney. Jas is a renowned surgeon, and we were very grateful to him for sharing his time and expertise with us.

Things we covered:
Multidisciplinary teams – the importance of these, and the types of discussions they have
Factors that are considered when considering surgery for a person with NETs
What sort of factors would lead to a recommendation for taking out a primary tumour?
What sort of factors would lead to a recommendation for taking out a secondary tumour?
Liver recovery after surgery
Operating when there has been prior treatment (such as PRRT, SIRT)
Somatostatin analogues and gallbladders
Liver transplantation

Helpful links:
NeuroEndocrine Cancer Australia, patient resources: https://neuroendocrine.org.au/resources/patient-resources/
Cancer Council Australia – general information about surgery: https://www.cancer.org.au/cancer-information/treatment/surgery

To contact Kate Wakelin (NET Nurse), email NETNurse@neuroendocrine.org.au or call 1300 287 363.

This video was originally broadcast into our Facebook Private Discussion Group. If you are affected by NETs (either as a patient or carer) and in Australia, you’re welcome to join this group – www.facebook.com/groups/472805285594/ (once you click on “Join Group”, you will be guided to answer three questions, so we can approve your membership). Our Carers group is at www.facebook.com/groups/797093257354706

Please note that the information provided in this video is general, and not intended to be a substitute for professional advice. Always seek the guidance of your doctor or other qualified professional with any questions you may have regarding your own health or a medical concern.

Jump to section

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.